Intern, NDCP (Undergraduate)

Revolution Medicines•Redwood City, CA

4d•$67,000 - $81,000•Hybrid

About The Position

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated Clinical Pharmacology Summer Intern to support ongoing clinical development programs. The intern will work closely with clinical pharmacologists, pharmacometricians and cross functional members to contribute to PK/PD to inform dose selection and clinical strategy. The interns will have opportunities to assist in the analysis and interpretation of clinical PK/PD data, support noncompartmental and /or model-based analyses, contribute to study protocol, clinical study report and internal presentations, and attend team meetings/scientific discussions related to drug development.

Requirements

Currently pursuing a Bachelor’s degree in Biomedical Engineering, System Biology, or related field
Curiosity and eagerness to learn about drug development
Strong analytical and quantitative skills
Good time management and organizational skills
Ability to work independently and in a team environment
Strong written and verbal communication skills